A COVID-19 vaccine candidate backed by a project to develop more accessible and affordable jabs has entered late-stage trials.
Vaccine candidate backed by project to develop affordable jabs begins late-stage trials
A COVID-19 vaccine candidate backed by a project to develop more accessible and affordable jabs has entered late-stage trials.